Myriad Genetics (MYGN) Return on Capital Employed Growth (1y) (2012 - 2026)
Myriad Genetics (MYGN) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | -17.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 42.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 768.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 44.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -18.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 732.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -1,014.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -251.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 109.00 |
| 10 | Myriad Genetics | 300.99 Mn | 185.79 Mn | 127.00 Mn | 4,625.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,625.00 |
| Mar 31, 2026 | -5,507.00 |
| Dec 31, 2025 | -5,249.00 |
| Sep 30, 2025 | -6,334.00 |
| Jun 30, 2025 | -4,858.00 |
| Mar 31, 2025 | 935.00 |
| Dec 31, 2024 | 1,209.00 |
| Sep 30, 2024 | 1,655.00 |
| Jun 30, 2024 | 1,106.00 |
| Mar 31, 2024 | -766.00 |
| Dec 31, 2023 | -1,279.00 |
| Sep 30, 2023 | -1,686.00 |
| Jun 30, 2023 | -1,254.00 |
| Mar 31, 2023 | -97.00 |
| Dec 31, 2022 | 379.00 |
| Sep 30, 2022 | 839.00 |
| Jun 30, 2022 | 2,188.00 |
| Mar 31, 2022 | 3,195.00 |
| Dec 31, 2021 | 3,478.00 |
| Sep 30, 2021 | 2,486.00 |